Imhoff, the team's Diabetes/Endocrinology, Kellogg Eye Center, Nephrology and Rheumatology communicator, joined Michigan Medicine in 2019. She's passionate about storytelling and brand activism. Twitter: @JordynImhoff
For adults with type 2 diabetes, pairing basal insulin with continuous glucose monitoring improved blood sugar and quality of life.
A novel therapeutic may halt rapid kidney function in some type 1 diabetic kidney disease patients.
An analysis finds a “one size fits all” approach to prescribing opioids after surgery poses risks for addiction in certain patients.
In a subset of patients the hormone leptin can be leveraged as a therapeutic agent to move fat out of the liver.
A phase 3 clinical trial finds an anti-inflammatory drug used in rheumatoid arthritis can preserve lung function in patients with systemic sclerosis.
Inhibiting IRE1α, a molecule activated by the endoplasmic reticulum in neutrophils, counters disease progression in lupus mice.
